clinical trial · NCT03975829
Pediatric Long-Term Follow-up and Rollover Study
Diffuse AstrocytomaAnaplastic AstrocytomaAstrocytomaOligodendroglioma, ChildhoodAnaplastic OligodendrogliomaGlioblastomaPilocytic AstrocytomaGiant Cell Astrocytomadabrafenibtrametinib
brief summary
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
started
Nov 4, 2019
primary completion
Nov 5, 2026
completion
Nov 5, 2026
last updated
May 11, 2026
official title
An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol